Press Releases

CD Genomics Takes Genomic Research to New Heights with Ribo-seq Technology

Sygnature Discovery appoints new industry leaders to their board of directors

I'm getting in touch with the latest news from Sygnature Discovery, a world-leading contract research organization. The company has recently appointed two industry leaders, Vanessa Malier and Martin LeBlanc, to their board of directors, reinforcing its commitment to innovation and strategic leadership. With decades of experience and a wealth of expertise in their respective fields, both Martin and Vanessa bring unique and valuable perspectives to Sygnature Discovery's board.

CD Genomics Launches Full-Length 16S/18S/ITS Amplicon Sequencing Service

Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC

Creative Enzymes Unveils Cutting-edge Homocysteine Methyltransferase, Recombinant for Enhanced Bioprocessing

Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant

IntegrateRNA Unveils Revolutionary Self-Amplifying RNA In Vitro Synthesis Service

Microbialtec Announces Industry-Leading Microbial Identification Services under GMP Standards

Creative Proteomics Uplifts Protein Research with Cutting-Edge Molecular Mass Determination Services

Creative Biogene Provides One-stop PEM-Seq Service to Assess Off-target Effect of CRISPR/Cas9

Creative Proteomics Unleashes the Exosome Untargeted Metabolomics Service

Creative Proteomics Enhances Proteomics Research with Advanced Post-Translational Modification Analysis Services

Samsung Biologics engages suppliers to advance global decarbonization targets

Amerigo Scientific Releases Automated Liquid Handling Equipment to Modernize Pipetting Workflow

CD Formulation Provides Efficient Strategies to Develop and Optimize Microspheres & Microneedles

Vast Range of Quantum Dots Available at Alfa Chemistry to Foster Innovations in Biotechnology, Optoelectronics, and Catalysis

Symbiosis Pharmaceutical Services granted MHRA licence following a £1M Investment

“Inizio Launch Elevate” Set to Help Global Pharma Maximize Product Launch Potential

Inizio has announced the new launch of “Inizio Launch Elevate” which aims to accelerate global pharma product launches, harnessing the power of its specialist product launch expertise with an enhanced commercial offering

BOC Sciences Celebrates Nobel Prize Awarded to Scientists Behind COVID-19 Vaccines

BOC Sciences expressed its congratulations to Katalin Karikó and Drew Weissman for being recipients of the 2023 Nobel Prize in Physiology or Medicine.

This Thanksgiving, Alfa Chemistry Extends Gratitude with Special Offers